NCT01472016
- Conditions
- Advanced Solid Tumors, Neoplasms
- Locations
-
Not specified
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
7,968 public trials
1,514 recruiting studies
Neoplasms trial results
NCT01524978
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Arizona Oncology Tucson, Arizona, United States
- Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
- Massachusetts General Hospital;Oncology Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT01969669
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Site Reference ID/Investigator# 97498 Tucson, Arizona, United States
- Site Reference ID/Investigator# 92593 Lebanon, New Hampshire, United States
- Site Reference ID/Investigator# 101415 Hackensack, New Jersey, United States
NCT03228147
- Conditions
- Digestive System Diseases, Esophageal Diseases, Esophagitis, +7 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT02499861
- Conditions
- Cancer, Neoplasms
- Locations
-
- St. Justine's Hospital Montreal, Quebec, Canada
NCT00361803
- Conditions
- Cancer, Disease Attributes, Neoplasms, +3 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
NCT01231568
- Conditions
- Cancer, Neoplasms
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Nashville, Tennessee, United States
- GSK Investigational Site Salt Lake City, Utah, United States
NCT01954043
- Conditions
- Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- GSK Investigational Site Goodyear, Arizona, United States
- GSK Investigational Site Dallas, Texas, United States
- GSK Investigational Site Tacoma, Washington, United States
- GSK Investigational Site Heidelberg, Victoria, Australia
Completed
Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies
NCT02441465
- Conditions
- Malignant Melanoma, Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- Magyar Honvedseg Egeszsegugyi Kozpont Budapest, Hungary
Completed
VEG111485: A QTc Study of Pazopanib
NCT00861029
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Duarte, California, United States
- GSK Investigational Site Santa Monica, California, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States